Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥11.15 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	35.50
Forward PE	26.96
Price to Sales TTM	CN¥11.89
Price to Book MRQ	CN¥4.59
Enterprise to Revenue	10.27
Enterprise to EBITDA	26.77

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	33.59%
Operating Margin	33.43%
Return on Assets TTM	7.39%
Return on Equity TTM	12.29%

Income Statement

Revenue TTM	CN¥937,616,768
Revenue per Share TTM	CN¥1.79
Quarterly Revenue Growth	5.70%
Gross Profit TTM	CN¥891,252,992
EBITDA	CN¥358,907,623
Net Income to Common TTM	CN¥314,957,120
Diluted EPS TTM	CN¥0.60
Quarterly Earnings Growth YoY	-3.70%

Balance Sheet

Total Cash MRQ	CN¥1,286,165,120
Total Cash per Share MRQ	CN¥2.46
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.41
Current Ratio MRQ	19.06
Book Value per Share MRQ	CN¥4.64

Cash Flow

Operating Cash Flow TTM	CN¥304,552,416
Levered Free Cash Flow TTM	CN¥83,796,800

300357 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	523,584,000
Float Shares	257,189,697
Avg 10 Volume	6,374,114
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	52.07%
% Held by Institutions	8.13%

Stock Price Summary

Beta	0.83
Fifty Two Week Low	CN¥16.32
Fifty Two Week High	CN¥29.21
Fifty Two Week Change	10.52%
Day 50 MA	CN¥20.24
Day 200 MA	CN¥21.15

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.40
Forward Annual Dividend Yield	1.88%
Trailing Annual Dividend Rate	CN¥0.10
Trailing Annual Dividend Yield	0.47%
Payout Ratio	47.38%
Dividend Date
Ex Dividend Date	2025-01-10
Last Split Factor
Last Split Date	2019-05-08